Reproductive BioMedicine Online
Volume 20, Issue 2 , Pages 182-190 , February 2010

Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility

  • C.M. Howles

      Affiliations

    • Merck Serono S.A. – Geneva, Switzerland an affiliate of Merck KGaA, Darmstadt, Germany
    • Corresponding Author InformationCorresponding author.
    • ,
  • V. Alam

      Affiliations

    • Merck Serono S.A. – Geneva, Switzerland an affiliate of Merck KGaA, Darmstadt, Germany
    • ,
  • D. Tredway

      Affiliations

    • EMD Serono an affiliate of Merck KGaA, Darmstadt, Germany, Global Development, Rockland, MA, USA
    • ,
  • R. Homburg

      Affiliations

    • Barzilai Medical Centre, Ashkelon, Israel
    • ,
  • D.W. Warne

      Affiliations

    • Merck Serono S.A. – Geneva, Switzerland an affiliate of Merck KGaA, Darmstadt, Germany

Received 27 April 2009 ,Revised 4 June 2009 ,Accepted 11 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Howles is Head of Medical Affairs Fertility, Europe, for Merck Serono S.A. – Geneva, Switzerland. Previously, he worked in clinical development, and spent almost 3years in the Far East. During the 1980s and 1990s he was involved in the development of the first highly purified recombinant FSH (follitropin alfa), human LH, human chorionic gonadotrophin and the gonadotropin-releasing hormone antagonist, cetrorelix. Dr Howles is the author or editor of more than 50 publications on reproductive endocrinology and two textbooks on reproductive medicine. His current research focuses on identifying patient characteristics as prognostic factors of ovarian response following FSH stimulation in ovulation induction and assisted reproduction treatment cycles.

PII: S1472-6483(09)00230-2

doi: 10.1016/j.rbmo.2009.11.017

Reproductive BioMedicine Online
Volume 20, Issue 2 , Pages 182-190 , February 2010

Article Tools

* Image Usage & Resolution